Dr. Lori Mosca, a noted cardiologist, researcher and preventive cardiology leader, who was part of a scientific team that has advised Aralez on patient needs and the gastrointestinal-related obstacles discusses
· Why heart disease and stroke remain the country’s number-one killer, and the importance of secondary prevention.
· The latest clinical guidelines and treatment for secondary prevention of heart attack and stroke.
· How patients and health care providers alike grapple with the gastrointestinal symptoms of daily aspirin therapy.
· Why discontinuing aspirin due to gastrointestinal events is not an acceptable option for secondary prevention patients.
· How patients can better manage their condition, and measures they can take to prevent recurrent heart attack or stroke.
